№46 / М.Русова


1.Selye H. A Syndrome Produced by Diverse Nocuous Agents. Nature, 1936, 138. Р. 32. 

2.Cohen S., Janicki-Deverts D., Miller G. E. Psychological stress and disease. JAMA, 2007, 298 (14). Р. 1685–1687. 

3.Smith S. M., Vale W. W. The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin. Neurosci., 2006, 8 (4). Р. 383–395. 

4.Arun C. P. Fight or flight, forbearance and fortitude: the spectrum of actions of the catecholamines and their cousins. Ann. N. Y. Acad. Sci., 2004, 1018. Р. 137–140. 

5.Chen Y., Lyga J. Brain-skin connection: stress, inflammation and skin aging. Inflamm. Allergy. Drug. Targets., 2014, 13 (3). Р. 177–190. 

6.Dunn J. H., Koo J. Psychological Stress and skin aging: A review of possible mechanisms and potential therapies. Dermatol. Online J., 2013, 19 (6). Р. 18561. 

7.Lin T. K., Zhong L., Santiago J. L. Association between Stress and the HPA Axis in the Atopic Dermatitis. Int. J. Mol. Sci., 2017, 18 (10). 

8.Thota R. N., Ferguson J. J., Abbott K. A. et al. Science behind the cardio-metabolic benefits of omega-3 polyunsaturated fatty acids: biochemical effects vs. clinical outcomes. Food Funct., 2018, 9 (7). Р. 3576–3596. 

9.Sparavigna A., Tenconi B., De Ponti I. Antiaging, photoprotective, and brightening activity in biorevitalization: a new solution for aging skin. Clin. Cosmet. Investig. Dermatol., 2015, 8. Р. 57–65. 

10.Neuman M. G., Nanau R. M., Oruña-Sanchez L., Coto G. Hyaluronic acid and wound healing. J. Pharm. Pharm. Sci., 2015, 18 (1). Р. 53–60. 

11.Girish K. S., Kemparaju K. The magic glue hyaluronan and its eraser hyaluronidase: a biological overview. Life Sci., 2007, 80 (21). Р. 1921–1943. 

12.Чайковская Е. А., Парсагашвили Е. З., Софинская Г. Л. «‎Гиалуроновая кислота в форме пролекарства? Теоретические основы разработки препаратов и клиническая практика их применения»‎. «‎Инъекционные методы в косметологии», ‎2017, 2. С. 28–43. 

13.Stern R., Asari A. A., Sugahara K. N. Hyaluronan fragments: an information-rich system. Eur. J. Cell. Biol., 2006, 85 (8). Р. 699–715. 

14.Litwiniuk M., Krejner A., Speyrer M. S., Gauto A. R., Grzela T. Hyaluronic Acid in Inflammation and Tissue Regeneration. Wounds, 2016, 28 (3). Р. 78–88. 

15.Kaya G., Tran C., Sorg O. et al. Hyaluronate fragments reverse skin atrophy by a CD44-dependent mechanism. PLoS. Med., 2006, 3 (12), e493. 

16.Bourguignon L. Y. Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormalepidermal functions. Am. J. Pathol., 2014, 184 (7). Р, 1912–1919. 

17.Soranzo C., Renier D., Pavesio A. Synthesis and characterization of hyaluronan-based polymers for tissue engineering. Methods Mol. Biol., 2004, 238. Р. 25–40. 

18.Wohlrab J., Wohlrab D., Neubert R. H. Comparison of noncross-linked and crosslinked hyaluronic acid with regard to efficacy of the proliferative activity of cutaneous fibroblasts and keratinocytes in vitro. J. Cosmet. Dermatol., 2013, 12 (1). Р. 36–40. 

19.Pluda S., Pavan M., Galesso D., Guarise C. Hyaluronic acid autocrosslinked polymer (ACP): Reaction monitoring, process investigation and hyaluronidase stability. Carbohydr. Res., 2016, 433. Р. 47–53. 

20.Alessandrini A., Di Bartolo C., Pavesio A., Pressato D. ACP gel: a new hyaluronic acid-based injectable for facial rejuvenation. Preclinical data in a rabbit model. Plast. Reconstr. Surg., 2006, 118 (2). Р. 341–346. 

21.Гришо О., Камелина Л. «‎Структура, свойства и применение гиалуроновой кислоты в медицине. Новая модификация гиалуроновой кислоты — эфир АСР»‎. «‎Эстетическая медицина», ‎2008, 7 (3). С. 3–8.